Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
KYNB
— Kyntra Bio, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 11, 2026
REVENUE
$3.7M
+192.7%
NET MARGIN
-406.6%
-3377.8 PTS
EPS
-$3.76
-140.1%
FREE CASH FLOW
-$13.9M
+24.2%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →